Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardlytics, Inc.CDLX · Entity 7603 | Chief Financial Officer | July 18, 2023 | July 20, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardlytics, Inc.
Report date July 18, 2023 · Filed July 20, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,775 |
Ending reported balance
After 2023-07-19 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-07-18 · Exercise / conversion · Acquired 30,147 · Balance 84,179 F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Row 2 · 2023-07-19 · Sale · Disposed 13,404 · Balance 70,775 F2: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on July 18, 2023 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.92 to $10.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the range set forth in this footnote |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-07-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-07-18 · Exercise / conversion · Acquired 30,147 · Balance 0 F4: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F5: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
F2: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on July 18, 2023
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.92 to $10.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F4: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F5: The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 05, 2021 Filed Nov 8, 2021 17:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 350 | $90.51 | $31,678.50 |
DisclosureSEC source: 0001666071-21-000222 · wf-form4_163641037425146.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,694 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $90.44 to $90.66, inclusive. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 17:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,583 | $90.21 | $142,802.43 |
DisclosureSEC source: 0001666071-21-000222 · wf-form4_163641037425146.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,044 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $89.43 to $90.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 08:09 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $81.12 | $20,280.00 |
DisclosureSEC source: 0001666071-21-000202 · wf-form4_163404055277335.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,627 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| October 06, 2021 Filed Oct 6, 2021 18:06 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000194 · wf-form4_163355797499830.xml · derivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. F3 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. Read SEC document |
| October 06, 2021 Filed Oct 6, 2021 18:06 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantPerformance Stock Unit · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000194 · wf-form4_163355797499830.xml · derivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. F3 · derivative.expiration_date: On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. Read SEC document |
| October 06, 2021 Filed Oct 6, 2021 18:06 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 3,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-21-000194 · wf-form4_163355797499830.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. F2 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| September 10, 2021 Filed Sep 10, 2021 16:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $94.56 | $23,640.00 |
DisclosureSEC source: 0001666071-21-000179 · wf-form4_163130554120778.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,127 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| September 03, 2021 Filed Sep 7, 2021 17:18 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $99.00 | $24,750.00 |
DisclosureSEC source: 0001666071-21-000175 · wf-form4_163104949046879.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,377 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 17:22 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $87.90 | $21,975.00 |
DisclosureSEC source: 0001666071-21-000162 · wf-form4_162871695230687.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,627 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| July 12, 2021 Filed Jul 12, 2021 16:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 750 | $122.30 | $91,725.00 |
DisclosureSEC source: 0001666071-21-000146 · wf-form4_162612288941475.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,877 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 16:17 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 500 | $119.00 | $59,500.00 |
DisclosureSEC source: 0001666071-21-000138 · wf-form4_162439304894239.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,627 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 500 | $110.28 | $55,140.00 |
DisclosureSEC source: 0001666071-21-000136 · wf-form4_162344276682042.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,127 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:34 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $99.00 | $24,750.00 |
DisclosureSEC source: 0001666071-21-000097 · wf-form4_162162924258689.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,627 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F2 · balance_after: Includes 221 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 10, 2021 Filed May 11, 2021 18:32 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $98.25 | $24,562.50 |
DisclosureSEC source: 0001666071-21-000088 · wf-form4_162077232536742.xml · nonDerivative · entry 7 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,656 F7 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| May 07, 2021 Filed May 11, 2021 18:32 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 50 | $105.15 | $5,257.50 |
DisclosureSEC source: 0001666071-21-000088 · wf-form4_162077232536742.xml · nonDerivative · entry 6 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,906 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021. Read SEC document |
| May 07, 2021 Filed May 11, 2021 18:32 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 204 | $104.02 | $21,220.08 |
DisclosureSEC source: 0001666071-21-000088 · wf-form4_162077232536742.xml · nonDerivative · entry 5 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,956 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021. F6 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $104.01 to $104.06, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 18:32 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 550 | $103.46 | $56,903.00 |
DisclosureSEC source: 0001666071-21-000088 · wf-form4_162077232536742.xml · nonDerivative · entry 4 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,160 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $102.99 to $103.98, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 18:32 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 850 | $102.25 | $86,912.50 |
DisclosureSEC source: 0001666071-21-000088 · wf-form4_162077232536742.xml · nonDerivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,710 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $101.93 to $102.83, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 18:32 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,000 | $100.98 | $100,980.00 |
DisclosureSEC source: 0001666071-21-000088 · wf-form4_162077232536742.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,560 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $100.61 to $101.55, inclusive. Read SEC document |
| May 07, 2021 Filed May 11, 2021 18:32 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 287 | $99.93 | $28,679.91 |
DisclosureSEC source: 0001666071-21-000088 · wf-form4_162077232536742.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,560 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $99.59 to $100.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5) and (6) to this Form 4. Read SEC document |
| April 27, 2021 Filed Apr 27, 2021 17:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 500 | $139.00 | $69,500.00 |
DisclosureSEC source: 0001666071-21-000075 · wf-form4_161956024744397.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,847 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| April 14, 2021 Filed Apr 14, 2021 17:53 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $119.00 | $29,750.00 |
DisclosureSEC source: 0001666071-21-000071 · wf-form4_161843722362712.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,347 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 17:53 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 500 | $109.95 | $54,975.00 |
DisclosureSEC source: 0001666071-21-000071 · wf-form4_161843722362712.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,597 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 17:52 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Unit · Derivative | 13,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000058 · wf-form4_161783232143617.xml · derivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,635 Underlying: Common Stock · 13,635 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:18 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 9,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000049 · wf-form4_161766818358816.xml · derivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,033 Underlying: Common Stock · 9,677 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:18 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 9,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000049 · wf-form4_161766818358816.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 16:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 750 | $131.45 | $98,587.50 |
DisclosureSEC source: 0001666071-21-000037 · wf-form4_161558399526665.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,420 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 17:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,000 | $155.49 | $155,490.00 |
DisclosureSEC source: 0001666071-21-000010 · wf-form4_161316844665323.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,170 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 19:49 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 750 | $143.75 | $107,812.50 |
DisclosureSEC source: 0001666071-21-000004 · wf-form4_161058538017538.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,170 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 19:49 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 250 | $143.57 | $35,892.50 |
DisclosureSEC source: 0001666071-21-000004 · wf-form4_161058538017538.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,920 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 17:11 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 390 | $120.49 | $46,991.10 |
DisclosureSEC source: 0001666071-20-000297 · wf-form4_160677425949462.xml · nonDerivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,170 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on November 25, 2020. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $120.26 to $120.68, inclusive. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 17:11 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 481 | $119.91 | $57,676.71 |
DisclosureSEC source: 0001666071-20-000297 · wf-form4_160677425949462.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,560 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on November 25, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $119.26 to $120.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4. Read SEC document |
| November 25, 2020 Filed Nov 30, 2020 17:11 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000297 · wf-form4_160677425949462.xml · derivative · entry 4 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested on May 25, 2020, 6 months after the Certification. The final twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested on November 25, 2020, 12 months after the Certification. F5 · derivative.expiration_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested on May 25, 2020, 6 months after the Certification. The final twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested on November 25, 2020, 12 months after the Certification. Read SEC document |
| November 25, 2020 Filed Nov 30, 2020 17:11 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-20-000297 · wf-form4_160677425949462.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,250 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000288 · wf-form4_160556329738067.xml · derivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,250 shares Expires 2026-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,250 | $112.54 | $365,755.00 |
DisclosureSEC source: 0001666071-20-000288 · wf-form4_160556329738067.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,166 Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 16:48 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 3,250 | $20.00 | $65,000.00 |
DisclosureSEC source: 0001666071-20-000288 · wf-form4_160556329738067.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 428 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 20:44 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 408 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000283 · wf-form4_160505904891201.xml · derivative · entry 5 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 408 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F5 · derivative.exercise_date: The RSUs are immediately vested. F5 · derivative.expiration_date: The RSUs are immediately vested. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 20:44 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 408 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000283 · wf-form4_160505904891201.xml · derivative · entry 4 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408 Underlying: Common Stock · 408 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F5 · derivative.exercise_date: The RSUs are immediately vested. F5 · derivative.expiration_date: The RSUs are immediately vested. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 20:44 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 112 | $100.40 | $11,244.80 |
DisclosureSEC source: 0001666071-20-000283 · wf-form4_160505904891201.xml · nonDerivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,738 F3 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on November 9, 2020. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $100.2907 to $100.405, inclusive. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 20:44 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 408 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000283 · wf-form4_160505904891201.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 20:44 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,725 | $89.30 | $332,642.50 |
DisclosureSEC source: 0001666071-20-000283 · wf-form4_160505904891201.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,442 F1 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $89.06 to $89.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 16:06 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 561 | $82.15 | $46,086.15 |
DisclosureSEC source: 0001666071-20-000256 · wf-form4_159864520005696.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on August 26, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $81.695 to $82.1548, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 16:06 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000256 · wf-form4_159864520005696.xml · derivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on February 26, 2020, 6 months after the Certification. The final twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on August 26, 2020, 12 months after the Certification. F4 · derivative.expiration_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on February 26, 2020, 6 months after the Certification. The final twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU vested on August 26, 2020, 12 months after the Certification. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 16:06 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-20-000256 · wf-form4_159864520005696.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 13, 2020 Filed Aug 13, 2020 19:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 54 | $79.16 | $4,274.64 |
DisclosureSEC source: 0001666071-20-000248 · wf-form4_159736084713844.xml · nonDerivative · entry 2 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on August 11, 2020. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 19:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 194 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000248 · wf-form4_159736084713844.xml · derivative · entry 4 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 194 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: .Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs are immediately vested. F3 · derivative.expiration_date: The RSUs are immediately vested. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 19:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 194 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000248 · wf-form4_159736084713844.xml · derivative · entry 3 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194 Underlying: Common Stock · 194 shares Expires not disclosed F1 · derivative.exercise_price: .Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F3 · derivative.exercise_date: The RSUs are immediately vested. F3 · derivative.expiration_date: The RSUs are immediately vested. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 19:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 194 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000248 · wf-form4_159736084713844.xml · nonDerivative · entry 1 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: .Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| July 20, 2020 Filed Jul 20, 2020 18:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,518 | $0.00 Strike: $24.48 | $0.00 |
DisclosureSEC source: 0001666071-20-000208 · wf-form4_159528521573856.xml · derivative · entry 6 Christiansen Andrew · CIK 0001805400 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,149 Underlying: Common Stock · 2,518 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.